Status:
COMPLETED
The Role of Netrin -1 in Acute Coronary Syndrome
Lead Sponsor:
Aksaray University Training and Research Hospital
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In our study, Netrin -1; We found that patients with ACS increased at the time of admission, decreased TIMI 3 flow after angiography, and higher risk groups in high risk groups such as TIMI and GRACE ...
Eligibility Criteria
Inclusion
- Patients over the age of 18
- diagnose ACS
- patients undergoing angiography
Exclusion
- CVE history
- Neurological disease
- Pregnancy and Lactation
- Liver failure
- Diagnosed malignity
- Use of anticonvulsant and nephrotoxic medication
- Chronic kidney disease
- Not having angiography
- Developing acute renal failure after angiography
- Patients who rejected to participate were excluded.
Key Trial Info
Start Date :
September 15 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2018
Estimated Enrollment :
238 Patients enrolled
Trial Details
Trial ID
NCT04027127
Start Date
September 15 2013
End Date
June 15 2018
Last Update
July 19 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.